An article by Stan Gibson and Samuel Buchman titled “How to Safeguard AI Technology: Patents versus Trade Secrets” was published by IPWatchdog on February 25, 2021.
In a decision published on April 27, 2020, the United States Patent and Trademark Office determined that only a human can be considered an inventor. So, who owns the patent when artificial intelligence makes the invention? What are the practical and logistical complications inherent in artificial intelligence-created inventions? With technology advancing faster than the legal […]
An article by Stan Gibson titled “Deepfakes: dangers and developments,” was published by the Los Angeles Daily Journal on July 2, 2020.
For more information on how we can help your business, visit our COVID-19 Resource Center. Despite pushback from the insurance industry, businesses should not assume that no coverage exists for business income losses related to the COVID-19 pandemic. Knowing what to look for in your insurance policy can help you determine if you have a […]
Stan Gibson posted “Motion to Disqualify Based on Joint Defense Agreement Denied Where Agreement Did Not Create Implied Attorney-Client Relationship,” on the Patent Lawyer Blog on January 23rd, 2019.
Stan Gibson and Nahal Bahri’s article, “Preparing to Discuss Predictive Coding at the Rule 26(f) Conference,” was published by Wolters Kluwer in the March 2015 issue of The Computer & Internet Lawyer.
Stan Gibson’s article entitled, “Motion to Strike Expert Testimony in Comples Case Denied,” was published in the November 2014 issue of the IP Litigator.
Stan Gibson’s blog article, “Fujitsu v. Tellabs: The District Court Orders Additional Sanctions for Fujitsu’s Continued ‘Contemptuous Conduct,’” was picked up by Today’s General Counsel.
Stan Gibson and Nahal Bahri wrote “Chapter 9: Preparing to Discuss Predictive Coding at the Rule 26(f) Conference” which was included in PLI’s Course Handbook for the Electronic Discovery Institute, 2014.
By Stan Gibson and Greg Cordrey Download the PDF: Can Your DNA Be Patented? The Supreme Court Draws A Delicate Balance This article was originally published in the Orange County Business Journal. In Ass’n for Molecular Pathology v. Myriad Genetics, Inc., the Supreme Court held that a naturally occurring, isolated segment of DNA is a product […]